Dendritic Cell Subsets as Vectors and Targets for Improved Cancer Therapy
- 19 May 2010
- book chapter
- Published by Springer Nature
- Vol. 344, 173-192
Abstract
Current active immunotherapy trials have shown durable tumor regressions in a fraction of patients. However, the clinical efficacy of current vaccines is limited, possibly because tumors skew the immune system by means of myeloid-derived suppressor cells, inflammatory Type 2 T cells and regulatory T cells (Tregs), all of which prevent the generation of effector cells. To improve the clinical efficacy of cancer vaccines in patients with metastatic disease, we need to design novel and improved strategies that can boost adaptive immunity to cancer, help overcome Tregs and allow the breakdown of the immunosuppressive tumor microenvironment. This can be achieved by exploiting the fast increasing knowledge about the dendritic cell (DC) system, including the existence of distinct DC subsets. Critical to the design of better vaccines is the concept of distinct DC subsets and distinct DC activation pathways, all contributing to the generation of unique adaptive immune responses. Such novel DC vaccines will be used as monotherapy in patients with resected disease and in combination with antibodies and/or drugs targeting suppressor pathways and modulation of the tumor environment in patients with metastatic disease.Keywords
This publication has 130 references indexed in Scilit:
- Immunity to stemness genes in human cancerCurrent Opinion in Immunology, 2010
- Foxp3+ T Cells Induce Perforin-Dependent Dendritic Cell Death in Tumor-Draining Lymph NodesImmunity, 2010
- Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fateNature, 2010
- “MIATA”—Minimal Information about T Cell AssaysImmunity, 2009
- CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of MacrophagesCancer Cell, 2009
- Human Dendritic Cells Induce the Differentiation of Interleukin-21-Producing T Follicular Helper-like Cells through Interleukin-12Immunity, 2009
- Understanding human myeloid dendritic cell subsets for the rational design of novel vaccinesHuman Immunology, 2009
- Follicular Helper T Cells: Lineage and LocationImmunity, 2009
- Type-1 polarized dendritic cells primed for high IL-12 production show enhanced activity as cancer vaccinesCancer Immunology, Immunotherapy, 2009
- Functional Specializations of Human Epidermal Langerhans Cells and CD14+ Dermal Dendritic CellsImmunity, 2008